{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:30:32Z","timestamp":1760239832501,"version":"build-2065373602"},"reference-count":110,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.rdc.2006.12.002","type":"journal-article","created":{"date-parts":[[2007,3,15]],"date-time":"2007-03-15T06:55:26Z","timestamp":1173941726000},"page":"177-195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Vasculitis in the Geriatric Population"],"prefix":"10.1016","volume":"33","author":[{"given":"Carol A.","family":"Langford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2006.12.002_bib1","unstructured":"Kussmaul A, Maier R. \u00dcber eine bischer nicht beschriebene, eigent\u00fcmliche Arterienerkrankung (Periarteritis nodosa), die mit Morbus Brightii und rapid fortschreitender allgemeiner Muskell\u00e5hmung einhergeht. Deutsches Arch klin Med 1866;1:484\u2013518."},{"key":"10.1016\/j.rdc.2006.12.002_bib2","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/ajcp\/22.8.777","article-title":"Periarteritis nodosa: critical review","volume":"22","author":"Zeek","year":"1952","journal-title":"Am J Pathol"},{"key":"10.1016\/j.rdc.2006.12.002_bib3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides. Proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.12.002_bib4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0950-3579(97)80043-X","article-title":"Classification and epidemiology of the vasculitides","volume":"11","author":"Watts","year":"1997","journal-title":"Baillieres Clin Rheumatol"},{"key":"10.1016\/j.rdc.2006.12.002_bib5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.7326\/0003-4819-139-6-200309160-00015","article-title":"Giant-cell arteritis and polymyalgia rheumatica","volume":"139","author":"Weyand","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMra011913","article-title":"Polymyalgia rheumatica and giant-cell arteritis","volume":"347","author":"Salvarani","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib7","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/art.20227","article-title":"Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period","volume":"51","author":"Salvarani","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.12.002_bib8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0307-742X(21)00303-9","article-title":"Clinical manifestations of giant cell (temporal) arteritis","volume":"6","author":"Calamia","year":"1980","journal-title":"Clin Rheum Dis"},{"key":"10.1016\/j.rdc.2006.12.002_bib9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0161-6420(93)31608-8","article-title":"Visual prognosis in giant cell arteritis","volume":"100","author":"Aiello","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.rdc.2006.12.002_bib10","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0002-9394(99)80192-5","article-title":"Ocular manifestations of giant cell arteritis","volume":"125","author":"Hayreh","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.rdc.2006.12.002_bib11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F","article-title":"Disease pattern in cranial and large-vessel giant cell arteritis","volume":"42","author":"Brack","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.12.002_bib12","doi-asserted-by":"crossref","first-page":"987","DOI":"10.7326\/0003-4819-120-12-199406150-00003","article-title":"How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis?","volume":"120","author":"Achkar","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib13","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jama.1957.02970450023007","article-title":"Treatment of temporal arteritis with adrenal corticosteroids","volume":"163","author":"Birkhead","year":"1957","journal-title":"JAMA"},{"key":"10.1016\/j.rdc.2006.12.002_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/rheumatology\/31.2.103","article-title":"Prevention of blindness in giant cell arteritis by corticosteroid treatment","volume":"31","author":"Myles","year":"1992","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.rdc.2006.12.002_bib15","first-page":"471","article-title":"Giant cell arteritis","volume":"112","author":"Ross Russell","year":"1959","journal-title":"QJM"},{"key":"10.1016\/j.rdc.2006.12.002_bib16","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0161-6420(94)31102-X","article-title":"Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision","volume":"101","author":"Liu","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.rdc.2006.12.002_bib17","doi-asserted-by":"crossref","first-page":"845","DOI":"10.7326\/0003-4819-77-6-845","article-title":"Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings","volume":"77","author":"Fauchald","year":"1972","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.7326\/0003-4819-88-2-162","article-title":"Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study","volume":"88","author":"Huston","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.0954-6820.1977.tb15683.x","article-title":"Giant-cell arteritis, temporal arteritis and polymyalgia rheumatica. A retrospective study of 63 patients","volume":"201","author":"Sorensen","year":"1977","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.rdc.2006.12.002_bib20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.0954-6820.1981.tb11604.x","article-title":"Prognosis of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study on ninety patients treated with corticosteroids","volume":"209","author":"Bengtsson","year":"1981","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.rdc.2006.12.002_bib21","first-page":"1340","article-title":"Restricted dose and duration of corticosteroid treatment in patients with polymyalgia rheumatica and temporal arteritis","volume":"17","author":"Lundberg","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2006.12.002_bib22","first-page":"361","article-title":"Duration of corticosteroid therapy in giant cell arteritis","volume":"7","author":"Fernandez-Herlihy","year":"1980","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2006.12.002_bib23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7326\/0003-4819-134-2-200101160-00010","article-title":"Combined treatment of giant-cell arteritis with methotrexate and prednisone. A randomized, double-blind, placebo-controlled trial","volume":"134","author":"Jover","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib24","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/art.10262","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis","volume":"46","author":"Hoffman","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.12.002_bib25","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/art.20171","article-title":"Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis","volume":"50","author":"Nesher","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.12.002_bib26","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/art.1780371020","article-title":"Thoracic aortic aneurysm and rupture in giant cell arteritis. A descriptive study of 41 cases","volume":"37","author":"Evans","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.12.002_bib27","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7326\/0003-4819-122-7-199504010-00004","article-title":"Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study","volume":"122","author":"Evans","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib28","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.berh.2004.06.003","article-title":"Polymyalgia rheumatica","volume":"18","author":"Salvarani","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.rdc.2006.12.002_bib29","doi-asserted-by":"crossref","first-page":"672","DOI":"10.7326\/0003-4819-97-5-672","article-title":"Polymyalgia rheumatica: a 10-year epidemiologic and clinical study","volume":"97","author":"Chuang","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.1780400105","article-title":"Disease patterns and tissue cytokine profiles in giant cell arteritis","volume":"40","author":"Weyand","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.12.002_bib31","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7326\/0003-4819-121-7-199410010-00003","article-title":"Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis","volume":"121","author":"Weyand","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib32","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archinte.159.6.577","article-title":"Corticosteroid requirements in polymyalgia rheumatica","volume":"159","author":"Weyand","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib33","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-141-7-200410050-00005","article-title":"Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial","volume":"141","author":"Caporali","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib34","doi-asserted-by":"crossref","first-page":"568","DOI":"10.7326\/0003-4819-141-7-200410050-00015","article-title":"Methotrexate in polymyalgia rheumatica: kernel of truth or curse of Tantalus?","volume":"141","author":"Stone","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib35","first-page":"20","article-title":"Distinguishing polyarteritis nodosa from microscopic polyangiitis and implications for treatment","volume":"7","author":"Guillevin","year":"1995","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2006.12.002_bib36","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/art.1780390720","article-title":"Effect of classification on the incidence of polyarteritis nodosa and microscopic polyangiitis","volume":"39","author":"Watts","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.12.002_bib37","first-page":"1345","article-title":"Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome\u201362 patients","volume":"20","author":"Guillevin","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2006.12.002_bib38","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/0002-9343(78)90533-8","article-title":"Cyclophosphamide-induced remissions in advanced polyarteritis nodosa","volume":"64","author":"Fauci","year":"1978","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib39","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A","article-title":"Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients","volume":"44","author":"Gayraud","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.12.002_bib40","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1002\/1529-0131(199812)41:12<2100::AID-ART3>3.0.CO;2-J","article-title":"Treatment of polyarteritis nodosa and microscopic polyangiitis","volume":"41","author":"Guillevin","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.12.002_bib41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00005792-199601000-00003","article-title":"Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients","volume":"75","author":"Guillevin","year":"1996","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rdc.2006.12.002_bib42","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00002281-199701000-00006","article-title":"The spectrum and treatment of virus-associated vasculitides","volume":"9","author":"Guillevin","year":"1997","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2006.12.002_bib43","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00005792-199509000-00002","article-title":"Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients","volume":"74","author":"Guillevin","year":"1995","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rdc.2006.12.002_bib44","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/ard.53.5.334","article-title":"Treatment of polyarteritis nodosa related to hepatitis B virus with interferon-alpha and plasma exchanges","volume":"53","author":"Guillevin","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2006.12.002_bib45","first-page":"289","article-title":"Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges. A prospective trial in 33 patients","volume":"20","author":"Guillevin","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2006.12.002_bib46","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener granulomatosis: an analysis of 158 patients","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib47","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J","article-title":"An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients","volume":"43","author":"Reinhold-Keller","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.12.002_bib48","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-2796.1998.00324.x","article-title":"Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975-95: organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies","volume":"244","author":"Tidman","year":"1998","journal-title":"J Intern Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib49","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/1529-0131(200002)43:2<414::AID-ANR23>3.0.CO;2-0","article-title":"Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom","volume":"43","author":"Watts","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.12.002_bib50","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(85)91147-X","article-title":"Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis","volume":"1","author":"van der Woude","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2006.12.002_bib51","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/1529-0131(199809)41:9<1521::AID-ART2>3.0.CO;2-A","article-title":"Antineutrophil cytoplasmic antibodies","volume":"41","author":"Hoffman","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.12.002_bib52","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1182\/blood.V74.6.1888.1888","article-title":"Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase","volume":"74","author":"Niles","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.rdc.2006.12.002_bib53","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM198806233182504","article-title":"Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis","volume":"318","author":"Falk","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib54","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-111-1-28","article-title":"Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener's granulomatosis","volume":"111","author":"N\u00f6lle","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib55","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O","article-title":"Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study","volume":"43","author":"Boomsma","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.12.002_bib56","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/art.1780360312","article-title":"Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis","volume":"36","author":"Kerr","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.12.002_bib57","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1681\/ASN.V1371977","article-title":"ANCA are pathogenic\u2013oh yes they are!","volume":"13","author":"Falk","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.rdc.2006.12.002_bib58","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0889-857X(05)70237-4","article-title":"Are antineutrophil cytoplasmic antibodies pathogenic? Experimental approaches to understand the antineutrophil cytoplasmic antibody phenomenon","volume":"27","author":"Russell","year":"2001","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.rdc.2006.12.002_bib59","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00000478-199104000-00001","article-title":"Surgical pathology of the lung in Wegener's granulomatosis. Review of 87 open lung biopsies from 67 patients","volume":"15","author":"Travis","year":"1991","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.rdc.2006.12.002_bib60","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00000478-199006000-00006","article-title":"Interpretation of head and neck biopsies in Wegener's granulomatosis. A pathologic study of 126 biopsies in 70 patients","volume":"14","author":"Devaney","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.rdc.2006.12.002_bib61","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0272-6386(12)80171-5","article-title":"The pathology of vasculitis involving the kidney","volume":"24","author":"Jennette","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.rdc.2006.12.002_bib62","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00005792-197311000-00002","article-title":"Wegener's granulomatosis: studies in eighteen patients and a review of the literature","volume":"52","author":"Fauci","year":"1973","journal-title":"Medicine"},{"key":"10.1016\/j.rdc.2006.12.002_bib63","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/0003-4819-98-1-76","article-title":"Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years","volume":"98","author":"Fauci","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib64","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0002-9343(03)00077-9","article-title":"Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener's granulomatosis: extended follow-up and rate of relapse","volume":"114","author":"Langford","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib65","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies","volume":"349","author":"Jayne","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib66","doi-asserted-by":"crossref","first-page":"477","DOI":"10.7326\/0003-4819-124-5-199603010-00003","article-title":"Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis","volume":"124","author":"Talar-Williams","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib67","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/art.10459","article-title":"High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low-dose methotrexate","volume":"47","author":"Reinhold-Keller","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.12.002_bib68","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1681\/ASN.V1091965","article-title":"Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement","volume":"10","author":"Nowack","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.rdc.2006.12.002_bib69","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/art.20240","article-title":"Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis","volume":"51","author":"Langford","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.12.002_bib70","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","article-title":"Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"De Groot","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.12.002_bib71","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/art.1780380505","article-title":"An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone","volume":"38","author":"Sneller","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.12.002_bib72","doi-asserted-by":"crossref","first-page":"683","DOI":"10.7326\/0003-4819-143-9-200511010-00012","article-title":"Are there different forms of life in the antineutrophil cytoplasmic antibody universe?","volume":"143","author":"Hoffman","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib73","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","article-title":"Etanercept plus standard therapy for Wegener's granulomatosis","volume":"352","author":"WGET Research Group","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib74","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/art.21869","article-title":"Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial","volume":"54","author":"Stone","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.12.002_bib75","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/01.ASN.0000114554.67106.28","article-title":"Prospective study of TNF alpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis","volume":"15","author":"Booth","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.rdc.2006.12.002_bib76","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/art.20718","article-title":"Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"Keogh","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.12.002_bib77","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1164\/rccm.200507-1144OC","article-title":"Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial","volume":"173","author":"Keogh","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib78","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJM199607043350103","article-title":"Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis","volume":"335","author":"Stegeman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib79","doi-asserted-by":"crossref","first-page":"877","DOI":"10.7326\/0003-4819-117-10-877_2","article-title":"Pancytopenia from using trimethoprim and methotrexate","volume":"117","author":"Govert","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib80","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6","article-title":"Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients","volume":"42","author":"Guillevin","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.12.002_bib81","first-page":"467","article-title":"Microscopic polyarteritis: presentation, pathology and prognosis","volume":"56","author":"Savage","year":"1985","journal-title":"Q J Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib82","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1681\/ASN.V7133","article-title":"Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis","volume":"7","author":"Nachman","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.rdc.2006.12.002_bib83","first-page":"277","article-title":"Allergic granulomatosis, allergic angiitis and periarteritis nodosa","volume":"27","author":"Churg","year":"1951","journal-title":"Am J Pathol"},{"key":"10.1016\/j.rdc.2006.12.002_bib84","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005792-199901000-00003","article-title":"Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients","volume":"78","author":"Guillevin","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rdc.2006.12.002_bib85","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00005792-198403000-00001","article-title":"Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome","volume":"63","author":"Lanham","year":"1984","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rdc.2006.12.002_bib86","first-page":"477","article-title":"Allergic granulomatosis and angiitis (Churg-Strauss syndrome). Report and analysis of 30 cases","volume":"52","author":"Chumbley","year":"1977","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.rdc.2006.12.002_bib87","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1067\/mai.2001.117176","article-title":"The relationship of asthma therapy and Churg-Strauss syndrome: NIH workshop summary report","volume":"108","author":"Weller","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rdc.2006.12.002_bib88","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00002281-200101000-00005","article-title":"\u201cEssential\u201d cutaneous vasculitis: what every rheumatologist should know about vasculitis of the skin","volume":"13","author":"Stone","year":"2001","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2006.12.002_bib89","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0190-9622(98)70039-8","article-title":"Cutaneous small-vessel vasculitis","volume":"39","author":"Lotti","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.rdc.2006.12.002_bib90","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0025-6196(12)65016-2","article-title":"Cutaneous vasculitis: approach to diagnosis and systemic associations","volume":"65","author":"Gibson","year":"1990","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.rdc.2006.12.002_bib91","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00005792-199911000-00005","article-title":"Henoch-Schonlein purpura in children. Report of 100 patients and review of the literature","volume":"78","author":"Saulsbury","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rdc.2006.12.002_bib92","first-page":"60","article-title":"Long-term outcome of Schonlein-Henoch nephritis in the adult","volume":"31","author":"Fogazzi","year":"1989","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.rdc.2006.12.002_bib93","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0002-9343(70)80024-9","article-title":"Renal manifestations of Henoch-Schonlein syndrome in adults","volume":"49","author":"Ballard","year":"1970","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib94","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/art.1780400513","article-title":"Henoch-Schonlein purpura in adulthood and childhood: two different expressions of the same syndrome","volume":"40","author":"Blanco","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.12.002_bib95","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/1529-0131(200002)43:2<405::AID-ANR22>3.0.CO;2-5","article-title":"Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies","volume":"43","author":"Choi","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.12.002_bib96","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1002\/1529-0131(199912)42:12<2507::AID-ANR2>3.0.CO;2-#","article-title":"Cryoglobulinemic vasculitis","volume":"42","author":"Lamprecht","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.12.002_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0889-857X(05)70259-3","article-title":"Mixed cryoglobulinemia secondary to hepatitis C virus infection","volume":"22","author":"Agnello","year":"1996","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.rdc.2006.12.002_bib98","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/art.10107","article-title":"Hepatitis C virus infection and vasculitis: implications of antiviral and immunosuppressive therapies","volume":"46","author":"Vassilopoulos","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.12.002_bib99","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1182\/blood.V84.10.3336.3336","article-title":"Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study","volume":"84","author":"Dammacco","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.rdc.2006.12.002_bib100","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2002-09-2856","article-title":"Efficacy and safety of rituximab in type II mixed cryoglobulinemia","volume":"101","author":"Zaja","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.rdc.2006.12.002_bib101","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2002-10-3162","article-title":"Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20","volume":"101","author":"Sansonno","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.rdc.2006.12.002_bib102","first-page":"1283","article-title":"Analysis of steroid related complications and mortality in temporal arteritis: a 15-year survey of 43 patients","volume":"21","author":"Nesher","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2006.12.002_bib103","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/art.1780401213","article-title":"A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis","volume":"40","author":"Guillevin","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.12.002_bib104","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0002-9343(96)80066-0","article-title":"Long-term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener's Granulomatosis Classification Criteria Cohort","volume":"101","author":"Matteson","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib105","first-page":"795","article-title":"Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis","volume":"151","author":"Ognibene","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib106","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1056\/NEJM199212243272606","article-title":"Prevention and treatment of pneumocystis pneumonia","volume":"327","author":"Masur","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2006.12.002_bib107","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1002\/art.1780401022","article-title":"Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica","volume":"40","author":"Gabriel","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2006.12.002_bib108","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/rheumatology\/37.3.292","article-title":"The deleterious effects of low-dose corticosteroids on bone density in patients with polymyalgia rheumatica","volume":"37","author":"Pearce","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.rdc.2006.12.002_bib109","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0041-1345(98)00179-1","article-title":"Effect of allopurinol on the metabolism of azathioprine in heart transplant patients","volume":"30","author":"el-Gamel","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/j.rdc.2006.12.002_bib110","doi-asserted-by":"crossref","first-page":"427","DOI":"10.7326\/0003-4819-80-3-427_2","article-title":"Letter: azathioprine and allopurinol","volume":"80","author":"Prager","year":"1974","journal-title":"Ann Intern Med"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X06000901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X06000901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:05:19Z","timestamp":1760180719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X06000901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":110,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0889857X06000901"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2006.12.002","relation":{},"ISSN":["0889-857X"],"issn-type":[{"type":"print","value":"0889-857X"}],"subject":[],"published":{"date-parts":[[2007,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vasculitis in the Geriatric Population","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2006.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}